Towards an ideal source of mesenchymal stem cell isolation for possible therapeutic application in regenerative medicine

Biomedical Papers

Volumn 158, Issue 3, 2014, Pages 356-360

  Bellavia, Maurizio ^a,d   Altomare, Roberta ^a   Cacciabaudo, Francesco ^a   Santoro, Alessandra ^b   Allegra, Adolfo ^c   Gioviale, Maria Concetta ^a   Ignazio Lo Monte, Attilio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Department of Cardiology   (Italy)

^c Via Ausonia 43/45   (Italy)

^d Istituto Euro Mediterraneo di Scienza e Tecnologia (IEMEST)   (Italy)

Author keywords

Mesenchymal stem cells; Regenerative medicine; Stem cell markers

Indexed keywords

ADIPOSE TISSUE; AMNION FLUID; BONE MARROW CELL; CHORION VILLUS; CYTOLOGY; FEMALE; HUMAN; MESENCHYMAL STROMA CELL; PLACENTA; PREGNANCY; PROCEDURES; REGENERATIVE MEDICINE;

ADIPOSE TISSUE; AMNIOTIC FLUID; BONE MARROW CELLS; CHORIONIC VILLI; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; PLACENTA; PREGNANCY; REGENERATIVE MEDICINE;

EID: 84907618468     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2013.051     Document Type: Review

References (51)

1. Dominici M, Le Blank K, Mueller A, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8(4):315-7.
2. Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, Gao JL, Kim SH, Zhou JZ, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, Reid RR, Luu HH, Haydon RC, Deng ZL, He TC. Mesenchymal stem cells: Molecular characteristics and clinical applications. World Journal of Stem Cells 2010;2(4):67-80.
3. Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical trials for stem cell therapies. BMC Medicine 2010;9:52. doi: 10.1186/1741-7015-9-52
4. Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T. Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signalling. Journal of Cell Biology 2004;166(1):85-95.
5. Babu MM, Luscombe NM, Aravind L, Gerstein M, Teichmann SA. Structure and evolution of transcriptional regulatory networks. Current Opinion in Structural Biology 2004;14(3):283-91.
6. Pardo M, Lang B, Yu L, Prosser H, Bradley A, Babu MM, Choudhary J. An Expanded Oct4 Interaction Network: Implications for Stem Cell Biology, Development, and Disease. Cell Stem Cell 2010;6(4):382-95.
7. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-7.
8. Farmer SR. Regulation of PPARgamma activity during adipogenesis. International Journal of Obesity 2005;29(Suppl 1):S13-6.
9. Oishi K, Noguchi H, Yukawa H, Hayashi S. Differential ability of somatic stem cells. Cell Transplant 2009;18(5):581-9.
10. Akiyama, H. Control of chondrogenesis by the transcription factor Sox9. Modern Rheumatology 2009;18(3):213-9.
11. Choi YH, Burdick MD, Strieter RM. Human circulating fibrocytes have the capacity to differentiate osteoblast and chondrocytes. Int J Biochem Cell Biol 2010;42(5):662-71.
12. Mihu CM, Mihu D, Costin N, Rus Ciucă D, Suşman S, Ciortea R. Isolation and characterization of stem cells from the placenta and the umbilical cord. Romanian journal of Morphology and Embryology 2010;9(4):441-6.
13. Pappa KI, Anagnou NP. Novel sources of fetal stem cells: where do they fit on the delovpmental continuum? Regenerative Medicine 2009;4(3):423-33.
14. Pojda Z, Machaj EK, Oldak T, Gajkowska A, Jastrzewska M. Nonhematopoietic stem cells of fetal origin-how much of today’s enthusiasm will pass the time test? Folia Histochemica et Cytobiologica 2005;43(4):209-12.
15. Bieback K, Brinkmann I. Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy. World Journal of Stem Cells 2010;2(4):81-92.
16. Takechi K, Kuwabara Y, Mizuno M. Ultrastructural and immunohistochemical studies of Wharton’s jelly umbilical cord cells. Placenta 1993;14(2):235-245.
17. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC. Mesenchymal stem cells in the Wharton’s jelly of the human umbilical cord. Stem Cells 2004;22(7):1330-7.
18. Conconi MT, Burra P, Di Liddo R, Calore C, Turetta M, Bellini S, Bo P, Nussdorfer GG, Parnigotto PP. CD105+ Cells from Wharton’s jelly show in vitro and in vivo myogenic differentiation potential. International Journal of Molecular Medicine 2006;18(6):1089-96.
19. Sakuragawa N, Thangavel R, Mizuguchi M, Hirasawa M, Kamo I. Expression of markers for both neuronal and glial cells in human amniotic epithelial cells. Neuroscience Letters 1996;209(1):9-12.
20. Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschlager M. Oct-4-expressing cells in human amniotic fluid: a new source of stem cell research? Human Reproduction 2003;18(7):1489-93.
21. Carlin R, Davis D, Weiss M, Schultz B, Troyer D. Expression of early transcription factors Oct4, Sox2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reproductive Biology and Endocrinology 2006;4:8.
22. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Human Reproduction 2004;19(6):1450-6.
23. Kim J, Lee Y, Kim H, Hwang KJ, Kwon HC, Kim SK, Cho DJ, Kang SG, You J. Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Proliferation 2007;40(1):75-90.
24. Antonucci I, Iezzi I, Morizio E, Mastrangelo F, Mastrangelo F, Pantalone A, Mattioli-Belmonte M, Gigante A, Salini V, Calabrese G, Tetè S, Palka G, Stuppia L. Isolation of osteogenic progenitors from human amniotic fluid using a single step culture protocol. BMC Biotechnology 2009; 9:9.
25. Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, Papadaki HA, Antsaklis A, Anagnou NP. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cell and Development 2007;16(6):931-52.
26. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biology of Reproduction 2007;77(3):577-88.
27. Miki T, Strom SC. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Reviews and Reports 2006;2(2):133-42.
28. Hemberger M, Yang W, Natale D, Brown TL, Dunk C, Gargett CE, Tanaka S. Stem cells from fetal membranes. A Workshop Report. Placenta 2008;29(A):S17-S19.
29. Poloni A, Rosini V, Mondini E, Maurizi G, Mancini S, Discepoli G, Biasio S, Battaglini G, Berardinelli E, Serrani F, Leoni P. Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta. Cytotherapy 2008;10(7):690-97.
30. Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G, Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC. Isolation and characterization of cells from human term placenta: outcome of the First International Workshop on Placenta-Derived Stem Cells. Stem Cells 2008;26(2):300-11.
31. Armstrong L, Saretzki G, Peters H, et al. Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells 2005;23(4):516-29.
32. Strakova Z, Livak M, Krezalek M, Ihnatovych I. Multipotent properties of myofibroblasts cells derived from human placenta. Cell Tissue Research 2008;332(3):479-88.
33. Wu CC, Chao YC, Chen CN, Chien S, Chen YC, Chien CC, Chiu JJ, Linju Yen B. Synergism of biochemical and mechanical stimuli in the differentiation of human placenta-derived multipotent cells into endothelial cell. Journal of Biomechanics 2008;41(4):813-21.
34. Bárcena A, Kapidzic M, Muench MO, Gormley M, Scott MA, Weier JF, Ferlatte C, Fisher SJ. The human placenta is a hematopoietic organ during the embryonic and fetal periods of development. Developmental Biology 2009;327(1):24-33.
35. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Ansorge W, Ho AD. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Experimental Hematology 2005;33(11):1402-16.
36. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogenic immune cell response. Blood 2005;105(4):1815-22.
37. Trounson A, Thakar RG, Lomax G, Gibbons D. Clinical trials for stem cell therapies. BMC Medicine 2011;9:52.
38. Arthur A, Zannettino A, Gronthos S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. Journal of Cell Physiology 2009;218(2):237-45.
39. Gioviale MC, Damiano G, Palumbo VD, Bellavia M, Cacciabaudo F, Cassata G, Puleio R, Altomare R, Lo Monte AI. Pancreatic islets from non-heart-beating donor pig: Two-layer preservation method in an in vitro porcine model. International Journal of Artificial Organ 2011;34(6):519-25.
40. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K, Ozawa K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007;109(1):228-34.
41. Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, Shen B, Yin S, Liu W, Cui L, Li N. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1. Cell Res 2008;18(8):846-57.
42. Kebriaei P, Robinson S. Treatment of graft-versus-host-disease with mesenchymal stomal cells. Cytotherapy 2011;13(3):262-8.
43. Bos C, Delmas Y, Desmoulière A, Solanilla A, Hauger O, Grosset C, Dubus I, Ivanovic Z, Rosenbaum J, Charbord P, Combe C, Bulte JW, Moonen CT, Ripoche J, Grenier N. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 2004,233(3):781-9.
44. Tadokoro M, Kanai R, Taketani T, Uchio Y, Yamaguchi S, Ohgushi H. New bone formation by allogenic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia. Journal of Pediatrics 2009;154(6):924-30.
45. Bellavia M, Gioviale MC, Damiano G, Palumbo VD, Cacciabaudo F, Altomare R, Buscemi G, Lo Monte AI. Is secondary hyperparathyroidism-related myelofibrosis a negative prognostic factor for kidney transplant outcome? Med Hypotheses 2011;77(4):557-9.
46. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M. Intravenous administration of human umbilical cord blood reduces behavioural deficits after stroke in rats. Stroke 2001;32(11):2682-8.
47. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS. Effect of stromal-cell-derived factor 1 on stem cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362:697-703.
48. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Science 2005;102(32):11474-79.
49. Caplan AI, Dennis JE. Mesenchymal stem cells as a trophic mediators. Journal of Cellular Biochemistry 2006;98(5):1076-84.
50. Borlongan CV, Lind JG, Dillon-Carter O, Yu G, Hadman M, Cheng C, Carroll J, Hess DC. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Research 2010;1010(1-2):108-16.
51. Brayfield CA, Marra KG, Rubin JP. Adipose tissue regeneration. Current Stem Cell Research and Therapy 2010;5(2):116-21.